Ovid Therapeutics Long Term Deferred Assets (Quarterly) Insights

Ovid Therapeutics, Inc. (OVID)

1.455 -0.02 (-1.02%) USD | NASDAQ | Feb 23, 10:32

View Long Term Deferred Assets (Quarterly) for OVID.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Cassava Sciences, Inc.	--
PTC Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--